SANUWAVE Health, Inc. SNWV
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2008-11-07
SANUWAVE Health, Inc. statistics & valuation
Market cap$74.0M
P / E6.3×
P / S1.7×
P / B45.7×
P / FCF38.3×
Net margin26.8%
FCF margin4.4%
Net debt$9.9M
Net debt / EBITDA1.7×
Enterprise value USD$84.0M
EV / EBITDA14.2×
Earnings yield EBIT/EV5.9%
Return on capital25.4%
Graham number -76.1%$1.28
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($1.28); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 77.1% | 75.2% | 70.4% | 74.1% | 61.7% | 71.4% | 32.0% | 62.5% | 67.2% | — |
| Operating margin | 11.2% | 11.8% | -2.6% | -53.5% | -108.7% | -621.1% | -575.3% | -388.1% | -517.8% | -241.0% |
| Net margin | 26.8% | -101.4% | -126.5% | -61.5% | -209.5% | -762.6% | -682.3% | -628.7% | -749.9% | -467.9% |
| FCF margin | 4.4% | 6.0% | -22.2% | — | -53.3% | -314.8% | -422.9% | -198.1% | -207.0% | -233.3% |
| Return on assets | 31.6% | -109.8% | -115.1% | -51.8% | -146.4% | -134.4% | -308.4% | -987.6% | -433.1% | -640.8% |
| Return on equity | 729.6% | 209.5% | 57.9% | 25.1% | 70.0% | 225.5% | 103.6% | 75.7% | 56.0% | 93.2% |
| Debt / equity | 13.52× | — | — | — | -0.67× | -1.22× | — | — | — | -0.78× |
| Current ratio | 1.38 | 0.41 | 0.15 | 0.11 | 0.08 | 0.22 | 0.20 | 0.07 | 0.11 | 0.12 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.